TrialFind
Saved trials
Back to results
Not yet recruiting
Phase 3
Thero2-01S22 in HER2-positive Breast Cancer
NCT05698186
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Contact
Valérie SARTORI
368767223
v.sartori@icans.eu
View on ClinicalTrials.gov
Official details
Thero2-01S22 in HER2-positive Breast Cancer — TrialFind